Elm3 Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.71M Sell
4,035
-74
-2% -$75K 3.13% 5
2025
Q4
$4.42M Sell
4,109
-789
-16% -$754K 3.66% 5
2025
Q3
$3.74M Sell
4,898
-1,016
-17% -$756K 3.06% 8
2025
Q2
$4.61M Sell
5,914
-503
-8% -$391K 3.83% 6
2025
Q1
$5.3M Sell
6,417
-478
-7% -$398K 4.66% 4
2024
Q4
$5.32M Buy
+6,895
New +$5.71M 4.54% 5

Other funds holding LLY

Elm3 Financial Group's LLY Position: Q1 2026 in Review

Elm3 Financial Group reduced its Eli Lilly (LLY) stake by 1.8% in Q1 2026, selling an estimated $75K and leaving 4,035 shares worth $3.71M. The position accounts for 3.13% of the portfolio, ranked #5.

Elm3 Financial Group first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.32M in Q4 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Elm3 Financial Group held 4,035 shares of Eli Lilly worth $3.71M as of Q1 2026.
  • Elm3 Financial Group sold 74 Eli Lilly shares in Q1 2026, an estimated $75K.
  • Eli Lilly made up 3.13% of Elm3 Financial Group's portfolio in Q1 2026, its #5 holding.
  • Elm3 Financial Group first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Elm3 Financial Group's Eli Lilly position peaked at $5.32M in Q4 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Elm3 Financial Group's 13F filing for Q1 2026, filed 13 Apr 2026.